X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2267) 2267
Publication (275) 275
Book Review (16) 16
Book Chapter (13) 13
Conference Proceeding (5) 5
Dissertation (5) 5
Data Set (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
rolipram (1586) 1586
animals (1420) 1420
phosphodiesterase inhibitors - pharmacology (868) 868
male (856) 856
humans (735) 735
rats (704) 704
rolipram - pharmacology (642) 642
pharmacology & pharmacy (615) 615
index medicus (534) 534
pyrrolidinones - pharmacology (523) 523
cyclic amp - metabolism (485) 485
cyclic nucleotide phosphodiesterases, type 4 (447) 447
mice (435) 435
3',5'-cyclic-amp phosphodiesterases - antagonists & inhibitors (377) 377
phosphodiesterase (366) 366
neurosciences (357) 357
camp (339) 339
female (322) 322
dose-response relationship, drug (289) 289
biochemistry & molecular biology (287) 287
3',5'-cyclic-amp phosphodiesterases - metabolism (275) 275
rats, sprague-dawley (231) 231
in vitro techniques (226) 226
cyclic amp (223) 223
expression (222) 222
colforsin - pharmacology (177) 177
phosphodiesterase inhibitors (174) 174
cells, cultured (170) 170
asthma (169) 169
cell biology (165) 165
cyclic-amp (164) 164
brain (162) 162
rats, wistar (160) 160
disease models, animal (159) 159
guinea pigs (158) 158
phosphorylation (155) 155
inflammation (151) 151
inhibitors (150) 150
phosphodiesterase inhibitors - therapeutic use (150) 150
cyclic nucleotide phosphodiesterases, type 4 - metabolism (147) 147
cells (140) 140
phosphodiesterase 4 inhibitors - pharmacology (137) 137
activation (135) 135
phosphoric diester hydrolases - metabolism (125) 125
kinetics (124) 124
cyclic-nucleotide phosphodiesterase (122) 122
cyclic-nucleotide phosphodiesterases (119) 119
pde4 (119) 119
3',5'-cyclic-amp phosphodiesterases - genetics (116) 116
time factors (116) 116
analysis (115) 115
rolipram - therapeutic use (115) 115
isoenzymes - metabolism (114) 114
immunology (112) 112
camp-specific phosphodiesterase (111) 111
cell line (110) 110
memory (109) 109
mice, inbred c57bl (109) 109
enzyme inhibitors - pharmacology (108) 108
rat (108) 108
in-vitro (107) 107
phosphodiesterase inhibitor (107) 107
1-methyl-3-isobutylxanthine - pharmacology (106) 106
chemistry, medicinal (106) 106
cyclic amp-dependent protein kinases - metabolism (105) 105
tumor-necrosis-factor (105) 105
article (103) 103
isoenzymes - antagonists & inhibitors (101) 101
inhibition (98) 98
signal transduction (98) 98
phosphodiesterase 4 inhibitors (91) 91
purinones - pharmacology (91) 91
signal transduction - drug effects (91) 91
molecular sequence data (89) 89
phosphodiesterases (89) 89
physiology (89) 89
proteins (88) 88
isoproterenol - pharmacology (86) 86
respiratory system (85) 85
rodents (85) 85
cyclic nucleotide phosphodiesterases, type 3 (84) 84
protein-kinase (84) 84
binding (83) 83
long-term potentiation (83) 83
tnf-alpha (83) 83
adult (82) 82
rat-brain (82) 82
structure-activity relationship (81) 81
psychiatry (80) 80
identification (79) 79
research article (78) 78
forskolin (77) 77
tumor necrosis factor-alpha - metabolism (77) 77
chemistry, organic (75) 75
pyridines - pharmacology (75) 75
research (74) 74
theophylline - pharmacology (74) 74
cyclic amp - physiology (73) 73
cyclic gmp - metabolism (73) 73
hippocampus (73) 73
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2248) 2248
Japanese (13) 13
German (8) 8
French (6) 6
Chinese (5) 5
Korean (2) 2
Polish (1) 1
Spanish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Cerebral Blood Flow & Metabolism, ISSN 0271-678X, 11/2018, Volume 38, Issue 11, pp. 2033 - 2040
Journal Article
Molecular Imaging and Biology, ISSN 1536-1632, 8/2018, Volume 20, Issue 4, pp. 615 - 622
Phosphodiesterase 4 (PDE4) inhibition in the brain has been reported to improve cognitive function in animal models. Therefore, PDE4 inhibitors are one of key... 
Primate | Roflumilast | Medicine & Public Health | Imaging / Radiology | PDE4 | PET | RODENTS | PHOSPHODIESTERASE-4 INHIBITOR | QUANTIFICATION | PERFORMANCE | IMPROVES MEMORY | ROLIPRAM | OBSTRUCTIVE PULMONARY-DISEASE | AFFINITY | IN-VIVO | DRUGS | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Benzamides - pharmacokinetics | Benzamides - blood | Humans | Aminopyridines - pharmacokinetics | Brain - enzymology | Cyclopropanes - blood | Macaca mulatta | Positron-Emission Tomography | Rolipram - blood | Aminopyridines - chemistry | Cyclopropanes - chemistry | Carbon Radioisotopes - chemistry | Animals | Aminopyridines - blood | Rolipram - pharmacokinetics | Aminopyridines - pharmacology | Female | Benzamides - pharmacology | Rolipram - chemistry | Cyclic Nucleotide Phosphodiesterases, Type 4 - metabolism | Rolipram - pharmacology | Benzamides - chemistry | Cyclopropanes - pharmacokinetics | Cyclopropanes - pharmacology | Binding | Brain | Animal models | Intravenous administration | Lung diseases | Cognitive ability | Positron emission | Phosphodiesterase IV | Inhibition (psychology) | Monkeys | Drug development | Studies | Rolipram | Inhibitors | Obstructive lung disease | Primates | Tomography | Emission measurements | Chronic obstructive pulmonary disease | Inhibition | Positron emission tomography | Phosphodiesterase
Journal Article
Current Pharmaceutical Design, ISSN 1381-6128, 01/2015, Volume 21, Issue 3, pp. 317 - 331
Journal Article
Journal Article
Journal of Microbiology and Biotechnology, ISSN 1017-7825, 2017, Volume 27, Issue 2, pp. 372 - 379
The transport of lysosomal enzymes into the lysosomes depends on the phosphorylation of their chains and the binding of the phosphorylated residues to... 
Lysosomes | rolipram | phosphodiesterase 4C
Journal Article
Journal Article
European Journal of Pharmacology, ISSN 0014-2999, 01/2015, Volume 746, pp. 138 - 147
Hypertension (HT) is a prevailing risk factor for cognitive impairment, the most common cause of vascular dementia; yet, no possible mechanism underlying the... 
Hypertension | Roflumilast N-oxide | Cognition | Rolipram | Roflumilast | N-oxide | OBJECT RECOGNITION MEMORY | SILENT BRAIN INFARCTS | COGNITIVE IMPAIRMENT | BLOOD-PRESSURE | PDE4 INHIBITORS | WHITE-MATTER LESIONS | OBSTRUCTIVE PULMONARY-DISEASE | RENIN-ANGIOTENSIN SYSTEM | PHARMACOLOGY & PHARMACY | LONG-TERM POTENTIATION | PITUITARY-ADRENAL AXIS | Memory - drug effects | Gene Expression Regulation, Enzymologic - drug effects | Rats, Wistar | Benzamides - metabolism | Cyclopropanes - blood | Male | Aminopyridines - metabolism | RNA, Messenger - metabolism | Brain - physiology | Brain - metabolism | Cognition - physiology | Benzamides - pharmacology | Blood Pressure - drug effects | Corticosterone - blood | Rolipram - pharmacology | Cyclopropanes - pharmacology | Phosphodiesterase 4 Inhibitors - blood | Benzamides - blood | Brain - physiopathology | RNA, Messenger - genetics | Cyclopropanes - metabolism | Rats | Phosphodiesterase 4 Inhibitors - metabolism | Rolipram - metabolism | Cyclic Nucleotide Phosphodiesterases, Type 4 - genetics | Cognition - drug effects | Maze Learning - drug effects | Phosphodiesterase 4 Inhibitors - pharmacology | Rolipram - blood | Hypertension - physiopathology | Brain - drug effects | Animals | Recognition (Psychology) - drug effects | Aminopyridines - blood | Aminopyridines - pharmacology | Clonidine | RNA | Gene expression | Protein binding | Index Medicus
Journal Article
PLoS ONE, ISSN 1932-6203, 09/2012, Volume 7, Issue 9, p. e43634
The extent of damage following spinal cord injury (SCI) can be reduced by various neuroprotective regimens that include maintaining levels of cyclic adenosine... 
CAMP-SPECIFIC PHOSPHODIESTERASE | DIFFERENTIAL EXPRESSION | MULTIDISCIPLINARY SCIENCES | CONTUSION INJURY | IMPROVES FUNCTIONAL RECOVERY | INHIBITOR ROLIPRAM | OLFACTORY ENSHEATHING GLIA | AMP-SPECIFIC PHOSPHODIESTERASE | RAT-BRAIN | SCHWANN-CELLS | NEURONAL DAMAGE | Oligodendroglia - metabolism | Spinal Cord Injuries - drug therapy | Motor Activity - drug effects | Rolipram - administration & dosage | Neuroglia - drug effects | Spinal Cord Injuries - pathology | Neuroprotective Agents - pharmacology | Oligodendroglia - drug effects | Spinal Cord Injuries - enzymology | Time Factors | Phosphodiesterase 4 Inhibitors - administration & dosage | Female | Neurons - metabolism | Phosphorylation - drug effects | Cyclic Nucleotide Phosphodiesterases, Type 4 - metabolism | Neurons - drug effects | Neuroprotective Agents - administration & dosage | Rolipram - pharmacology | Cell Survival - drug effects | Phosphoric Diester Hydrolases - metabolism | Phagocytes - drug effects | Axons - drug effects | Axons - metabolism | Rats | Phosphodiesterase 4 Inhibitors - pharmacology | Animals | Neuroglia - metabolism | Cytokines - biosynthesis | Complications and side effects | Enzyme inhibitors | Physiological aspects | Dosage and administration | Spinal cord injuries | Genetic aspects | Research | Drug therapy | Phosphodiesterases | Neuroprotection | Oxidative stress | Phosphorylation | Neurosciences | Multiple sclerosis | Spinal cord | Traumatic brain injury | Phosphodiesterase IV | Nervous system | Spinal cord injury | Kinases | Neuroprotective agents | Blood-brain barrier | Rodents | Oligodendrocytes | Paralysis | Phosphodiesterase | Adenosine | Cell survival | Adenosine monophosphate | Ethanol | Preservation | Cytokines | Cyclic AMP | Trauma | Medicine | Axons | Injury prevention | Rolipram | Inhibitors | Interleukin 10 | Infiltration | Alzheimers disease | Chemokines | Monocyte chemoattractant protein 1
Journal Article
Bioorganic & Medicinal Chemistry, ISSN 0968-0896, 10/2017, Volume 25, Issue 20, pp. 5709 - 5717
Journal Article
Neuroreport, ISSN 0959-4965, 05/2001, Volume 12, Issue 7, pp. 1507 - 1511
Proinflammatory cytokines are supposed to be involved in the pathophysiology of neuronal damage following excitotoxic lesions. We examined the effect of... 
rolipram
Journal Article